China Cord Blood Corporation announced that it has successfully completed $50 million convertible note financing with Golden Meditech Holdings Limited. The company's board has appointed Mr. Yuen Kam, currently the Chairman and Chief Executive Officer of Golden Meditech, as its director and Chairman, effective from October 3, 2012. Ms. Ting Zheng will continue her role as a member of the company's board and Chief Executive Officer of the company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.2 USD | 0.00% |
|
+9.09% | -1.64% |
2023 | Global Cord Blood Corporation Announces Board Appointments | CI |
2023 | Global Cord Blood Corporation(NYSE:CO) dropped from S&P Global BMI Index | CI |
1st Jan change | Capi. | |
---|---|---|
-1.64% | 161M | |
+19.84% | 83.16B | |
-25.24% | 73.08B | |
-1.34% | 26.15B | |
+4.56% | 17.9B | |
-9.29% | 17.39B | |
+4.52% | 15.94B | |
+78.16% | 13.61B | |
+77.84% | 13.06B | |
-26.14% | 12.76B |
- Stock Market
- Equities
- CORBF Stock
- News Global Cord Blood Corporation
- China Cord Blood Corporation Appoints Yuen Kam as Director and Chairman